Skip to main content
Clinical Trials/NCT04339361
NCT04339361
Unknown
Phase 4

Comparative Safety and Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in Relieving Pain During Levonorgestrel IUD Insertion

Cairo University0 sites111 target enrollmentApril 25, 2020

Overview

Phase
Phase 4
Intervention
lidocaine spray
Conditions
Contraception
Sponsor
Cairo University
Enrollment
111
Primary Endpoint
pain during IUD insertion
Last Updated
6 years ago

Overview

Brief Summary

the aim of this study is to compare the safety and Efficacy of Lidocaine Spray Versus Vaginal dinoprostone in relieving pain during levonorgestrel IUD Insertion in nulliparous women

Registry
clinicaltrials.gov
Start Date
April 25, 2020
End Date
August 15, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Samy aly ashour

assistant professor obstetrics and gynecology

Cairo University

Eligibility Criteria

Inclusion Criteria

  • nulliparous women requesting levonorgestrel IUD insertion

Exclusion Criteria

  • multiparous women, allergy or contraindication to study drugs or contraindications to LNG-IUD insertion

Arms & Interventions

lidocaine spray

four puffs (50ml, 10 mg/puff) of lidocaine spray will be applied to the cervical canal and cervix before tenaculum placement plus vaginal placebo will be given 3 hours before IUD insertion

Intervention: lidocaine spray

vaginal dinoprostone

vaginal dinoprostone 3 mg will be given 3 hours before IUD insertion plus four puffs of saline spray will be applied to the cervical canal and cervix before tenaculum placement

Intervention: vaginal dinoprostone

placebo

vaginal placebo will be given 3 hours before IUD insertion plus four puffs of saline spray will be applied to the cervical canal and cervix before tenaculum placement

Intervention: placebo

Outcomes

Primary Outcomes

pain during IUD insertion

Time Frame: 2 minutes

pain during IUD insertion assessed by 10 cm visual analog scale where 0 denotes no pain and 10 denotes the worst pain imaginable

Secondary Outcomes

  • insertion duration(5 minutes)

Similar Trials